schizophrenia

September 19, 2013

Transporter linked to autism risk

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

By Bill Snyder
July 17, 2012

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

By Leigh MacMillan
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

By VUMC News and Communications
Brain and doorway concept
April 6, 2012

Minds wide open: Neuroscience at Vanderbilt

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

By Bill Snyder
Brain image
February 16, 2012

Memory intact in early psychosis

Brain deficits are not present in the early stages of schizophrenia, suggesting it may be possible to delay or prevent the development of brain abnormalities.

By Leigh MacMillan
(iStock)
February 8, 2012

Tool finds connections in genome data

A new analytical tool points to genes that act together to increase disease risk.

By Leigh MacMillan
October 21, 2011

Information flow reduced in psychosis

Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.
By Leigh MacMillan
October 3, 2011

Researchers strive to refill drug discovery ‘pipeline’

By Bill Snyder
July 29, 2011

Connecting the dots in schizophrenia

Abnormalities of the hippocampus, a seahorse-shaped brain region involved in learning and memory, may play a role in the psychotic symptoms and cognitive deficits of schizophrenia.
By VUMC News and Communications
March 11, 2011

Neuroscience drug discovery center opens at Vanderbilt

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.
By Bill Snyder
1 2 3 4 5